Synthesis of betulinic acid derivatives as entry inhibitors against HIV-1 and bevirimat-resistant HIV-1 variants

References

Page 1

	Year	Citations
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry J Michael Kilby, Sam Hopkins, Thomas M. Venetta, Nature Medicine Human RetrovirusImmunologyAntiviral ResponseMolecular BiologyVirology	1998	991
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. Quentin J. Sattentau, John P. Moore The Journal of Experimental Medicine Virus StructureViral ReplicationHuman Immunodeficiency VirusProtein FoldingHuman Retrovirus	1991	598
Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV Agents Yoshiki Kashiwada, Fumio Hashimoto, L. Mark Cosentino, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyAntiviral DrugMolecular Pharmacology	1996	272
Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-<i>O</i>-(3′,3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection Patrick F. Smith, Abayomi Ogundele, Alan Forrest, Antimicrobial Agents and Chemotherapy	2007	192
Betulinic Acid Derivatives: A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry Françoise Soler, Christèle Poujade, Michel Evers, Journal of Medicinal Chemistry Bioorganic ChemistryImmunologyMolecular BiologyNew SeriesAntiviral Drug	1996	126
Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat Catherine S. Adamson, Michael Sakalian, Karl Salzwedel, Retrovirology	2010	92
Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1 Kurt Van Baelen, Karl Salzwedel, Evelien Rondelez, Antimicrobial Agents and Chemotherapy Primary ImmunodeficiencyGag SpacerBaseline SusceptibilityHuman RetrovirusPathogenesis	2009	88
Role of Human Immunodeficiency Virus (HIV) Type 1 Envelope in the Anti-HIV Activity of the Betulinic Acid Derivative IC9564 Sonia Holz-Smith, I‐Chen Sun, Lei Jin, Antimicrobial Agents and Chemotherapy	2001	85
Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives Li Huang, Phong Ho, Kuo‐Hsiung Lee, Bioorganic & Medicinal Chemistry Medicinal ChemistryAnti-hiv ActivityAntiviral Drug DevelopmentPharmacologyAntiviral Compound	2005	81
Phenotypic Susceptibility to Bevirimat in Isolates from HIV-1-Infected Patients without Prior Exposure to Bevirimat Nicolas Margot, Craig S. Gibbs, Michael D. Miller Antimicrobial Agents and Chemotherapy	2010	64

Page 1